Literature DB >> 25795315

Antimycobacterial activity of linezolid against multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis in Iran.

Hossein Kazemian1, Mehri Haeili2, Jalil Kardan Yamchi1, Faranak Rezaei1, Seifu Gizaw Feyisa3, Fatemeh Zahednamazi1, Parviz Mohajeri4, Saeed Zaker Bostanabd5, Abdolrazagh Hashemi Shahraki6, Abbas Ali Imani Fooladi7, Mohammad Mehdi Feizabadi8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25795315     DOI： 10.1016/j.ijantimicag.2015.02.004

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

1.  Mycobacterium tuberculosis Beijing Genotype in Western Iran: Distribution and Drug Resistance.

Authors:  Parviz Mohajeri; Sakineh Moradi; Sara Atashi; Abbas Farahani
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  Resistance of Mycobacterium tuberculosis strains to Rifampicin: A systematic review and meta-analysis.

Authors:  Seifu Gizaw Feyisa; Ahmed Abdulahi Abdurahman; Worku Jimma; Eshetu Ejeta Chaka; Jalil Kardan-Yamchi; Hossein Kazemian
Journal:  Heliyon       Date:  2019-01-01

3.  Efficacy Of Line Probe Assay In Detection Of Drug-Resistant Pulmonary Tuberculosis In Comparison With GeneXpert And Phenotypic Methods In Iran And Genetic Analysis Of Isolates By MIRU-VNTR.

Authors:  Hossein Kazemian; Jalil Kardan-Yamchi; Abbas Bahador; Shadi Khonsari; Mahshid Nasehi; Gholamreza Hamzehloo; Farzam Vaziri; Mohammad Reza Salehi; Mohammad Mehdi Feizabadi
Journal:  Infect Drug Resist       Date:  2019-11-15       Impact factor: 4.003

4.  Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived OPS in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis.

Authors:  Vahid Amini; Hossein Kazemian; Jalil Kardan Yamchi; Seifu Gizaw Feyisa; Saeed Aslani; Aref Shavalipour; Hamidreza Houri; Mohammadneshvan Hoorijani; Mehrdad Halaji; Hamid Heidari
Journal:  Iran Red Crescent Med J       Date:  2016-05-30       Impact factor: 0.611
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.